SignalXSignalX

Steris (STE) Q4 2025 10-Q Quarterly Report

Filed: Feb 6, 2026Period ending Dec 31, 2025
Health Care
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR
Steris Overview

Steris (STE) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 6, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Steris Q4 2025 10-Q Analysis

Management Discussion & Analysis

  • • Revenue $1,496.2M Q3 FY2026, up 9.2% YoY from $1,370.6M; nine months revenue $4,347.5M, up 9.3% from $3,979.0M
  • • Operating margin Q3 FY2026 18.2% ($273.2M/$1,496.2M) vs 17.9% YoY ($245.3M/$1,370.6M); nine months margin 18.1% vs 16.3% YoY
  • • Best segment: AST segment Q3 revenues +11.0%, operating margin 45.1% vs 44.8% YoY; worst segment: Healthcare margin down to 24.3% vs 25.3% YoY
  • • Operating cash flow $1,006.0M (+13.4% YoY), free cash flow $737.6M (+25.4% YoY); capital expenditures decreased to $278.8M from $299.2M
  • • Management notes inflation, tariff costs pressure margins; expects benefit from restructuring; sales growth driven by volume and pricing; no updated guidance disclosed

Risk Factors

  • • No new or updated risk factors reported since the fiscal 2025 10-K filed May 29, 2025
  • • Continued risks from product liability and regulatory compliance remain material, including FDA regulations on medical devices
  • • Ongoing market risk from competitive pressures in sterilization and healthcare sectors affecting near-term sales
  • • Exposure to foreign currency fluctuations impacting reported earnings due to international operations
  • • Debt refinancing risk due to upcoming maturities and variable interest rates described in 10-K

Steris Q4 2025 Quarterly Financials
XBRL

Revenue

$1.5B

▲ +9.2% YoY▲ +2.5% QoQ

Net Income

$193M

▲ +11.2% YoY▲ +0.6% QoQ

Net Margin

12.9%

▲ +23bp YoY▼ -24bp QoQ

Source: XBRL data from Steris Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Steris Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Steris

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.